Edition:
United Kingdom

ContraFect Corp (CFRX.OQ)

CFRX.OQ on NASDAQ Stock Exchange Capital Market

0.50USD
22 Apr 2019
Change (% chg)

$-0.03 (-5.73%)
Prev Close
$0.53
Open
$0.53
Day's High
$0.53
Day's Low
$0.48
Volume
213,497
Avg. Vol
224,700
52-wk High
$2.90
52-wk Low
$0.36

About

ContraFect Corporation is a clinical-stage biotechnology company. The Company is focused on discovering and developing therapeutic protein and antibody products for the treatment of infectious diseases, including those caused by drug-resistant pathogens, particularly those treated in hospital settings. Its pipeline of lysin... (more)

Overall

Beta: --
Market Cap(Mil.): $95.02
Shares Outstanding(Mil.): 73.66
Dividend: --
Yield (%): --

Financials

  CFRX.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -0.49 -- --
ROI: -104.45 8.91 13.83
ROE: -153.83 10.06 15.25

Earnings vs. Estimates